Binhui Biotech News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Binhui biotech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Binhui Biotech Today - Breaking & Trending Today

NeuShen Therapeutics Closes Pre-A Financing with ~$20M

/PRNewswire/ NeuShen Therapeutics, Inc., a biotechnology company focusing on developing innovative treatments for central nervous system (CNS) disorders. ....

United States , Yahong Meditech , Guangping Gao , Joan Shen , Zhihua Yu , Lilly Zhang , Aibo Medical Robot Co , Prnewswire Neushen Therapeutics Inc , Remegen Co , Horae Gene Therapy Center , Biostar Pharmaceuticals , Umass Chan Medical School , Shen Therapeutics , Chan Medical , Managing Director , Scientific Advisory , Lapam Capital , Betta Pharma , Clover Biopharmaceuticals , Stemirna Therapeutics , Binhui Biotech , Immuneonco Biopharmaceuticals , Aibo Medical Robot , Neushen Therapeutics ,

BridGene Biosciences Announces $38.5 Million Series B Financing to Further Develop Its Next Generation Chemoproteomics Platform and First-in-Class Oncology Drugs

/PRNewswire/ BridGene Biosciences, Inc., a biotechnology company leveraging a proprietary chemoproteomic platform to discover and develop small-molecule. ....

New York , United States , Hong Kong , Zhimeng Biopharma , Yahong Meditech , Mark Biosciences , Dave Schemelia , Jonathan Nugent , Yingli Pharma , Zhihua Yu , Bridgene Biosciences , Aibo Medical Robot Co , Biosciences Inc , Remegen Co , Biostar Pharmaceuticals , Allist Pharmaceuticals , Vigene Biosciences , Lapam Capital , Junson Capital , Takeda Pharmaceutical , Ping Cao , Betta Pharma , Clover Biopharmaceuticals , Stemirna Therapeutics , Binhui Biotech , Immuneonco Biopharmaceuticals ,

Chinese biotech firm Binhui secures $93m Series C led by Temasek's Vertex Ventures, others

Chinese biotech firm Binhui secures $93m Series C led by Temasek’s Vertex Ventures, others
Photo: Pixabay
February 10, 2021
Gene-focused biotechnology player Wuhan Binhui Biotech on Wednesday announced the completion of a 600 million yuan ($93 million) Series C round funding jointly led by healthcare-focussed Share Capital, Temasek’s Vertex Ventures China, Qianhai FOF, and CICC Capital’s sub-fund.
Returning investor Beijing Lapam Capital Management re-upped in the latest round, Binhui Biotech said in a WeChat post. Lapam had partnered Fortune Capital to seed 26.5 million yuan ($4 million) in Binhui in 2017. In 2018, Lapam exclusively poured 20 million yuan ($3 million) into the company.
With the latest Series C proceeds, Binhui expects to fund clinical trials, pipelines, and R&D platform advancements. ....

Tay Choon Chong , Wuhan Neurophth Biological Technology , Therapten Biosciences Inc Of Canada , Sequoia Capital , Wuhan Binhui Biotech , Share Capital , Vertex Ventures China , Beijing Lapam Capital Management , Binhui Biotech , Fortune Capital , Therapten Biosciences Inc , Lepu Medical , Wuhan East Lake Venture Capital , Neurophth Biological Technology , Northern Light Venture Capital , தாய் சூன் சோங் , சீக்வோயா மூலதனம் , பகிர் மூலதனம் , வெர்டெக்ஸ் முயற்சிகள் சீனா , அதிர்ஷ்டம் மூலதனம் , வடக்கு ஒளி துணிகர மூலதனம் ,